Insider · CIK 0001326969
Camille L Bedrosian
Files at RYTM (RHYTHM PHARMACEUTICALS, INC.), CRNX (Crinetics Pharmaceuticals, Inc.), AMLX (Amylyx Pharmaceuticals, Inc.). First filing Dec 3, 2024, latest Sep 14, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AMLX: Amylyx Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 44Moderate | Amylyx Pharmaceuticals, Inc. | $325k 10,028 shares | -3% | +182% from low-19% from high | |
| 36Weak | Amylyx Pharmaceuticals, Inc. | $43k 12,425 shares | -6% | +42% from low-50% from high | |
| 20Weak | AMLXsell Amylyx Pharmaceuticals, Inc. | $30k 5,421 shares | -4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -7,947 | $32.21 | $256k | 280,145 | 28 d ago |
| Sep 10, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -2,081 | $33.09 | $69k | 278,064 | 28 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Common Stock | -16,300 | $85.00 | $1.4M | 5,925 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Common Stock | -5,925 | $85.00 | $504k | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -25,000 | $68.92 | $1.7M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -17,500 | $64.77 | $1.1M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -17,500 | $66.71 | $1.2M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -17,500 | $64.68 | $1.1M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,500 | $40.29 | $504k | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,350 | $52.67 | $545k | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -9,730 | $49.13 | $478k | 0 | 41 d ago |
| Jun 24, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | AGrant or award Stock Option (right to buy)derivative | +7,037 | $0.00 | $0 | 7,037 | Jun 26, 2025 |
| Jun 24, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +4,712 | $0.00 | $0 | 4,712 | Jun 26, 2025 |
| Jun 18, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock | +4,000 | - | - | 7,000 | Jun 23, 2025 |
| Jun 18, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -4,000 | $0.00 | $0 | 0 | Jun 23, 2025 |
| Jun 11, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | AGrant or award Common Stock | +6,900 | $0.00 | $0 | 16,300 | Jun 13, 2025 |
| Jun 11, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +10,350 | $0.00 | $0 | 10,350 | Jun 13, 2025 |
| Mar 31, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -12,425 | $3.47 | $43k | 194,375 | Apr 2, 2025 |
| Mar 6, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | AGrant or award Common Stock | +68,420 | $0.00 | $0 | 206,800 | Mar 10, 2025 |
| Mar 6, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +102,630 | $0.00 | $0 | 102,630 | Mar 10, 2025 |
| Dec 2, 2024 | AMLX Amylyx Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -5,421 | $5.54 | $30k | 138,380 | Dec 3, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.